bioXXmed AG Logo

bioXXmed AG

A biomedical investor financing dermatology, wound care, and regenerative medicine firms.

T5O | F

Overview

Corporate Details

ISIN(s):
DE000A40ETB1 (+1 more)
LEI:
8945005J8KVO36IW6P49
Country:
Germany
Address:
Butzbacher Weg 6, 64289 Darmstadt
Sector:
Financial and insurance activities
Industry:
Other financial service activities, except insurance and pension funding activities

Description

bioXXmed AG is an investment holding company and active portfolio manager specializing in the biomedical sector. The company provides equity financing to innovative biotechnology and medical technology firms, with a current strategic focus on dermatology. Key investment areas include advanced wound care, particularly for diabetic conditions, and novel technologies in regenerative medicine. bioXXmed targets companies that possess patented, application-oriented technologies addressing high unmet medical needs and with long remaining patent lives. The firm actively supports its portfolio companies' development and commercialization efforts. The company was formerly known as CytoTools AG.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-28 12:18
M&A Activity
bioXXmed AG: Verbindliches Angebot fur die Tochtergesellschaft Rancoderm GmbH a…
German 10.2 KB
2025-06-27 16:35
Report Publication Announcement
bioXXmed AG informiert uber die Verzogerung der Veroffentlichung des gepruften …
German 6.2 KB
2025-02-21 20:29
Capital/Financing Update
bioXXmed AG beschliet Ausgabe einer Wandelschuldverschreibung unter Ausschluss …
German 7.0 KB
2024-06-27 00:00
Annual Report
German 3.7 MB

Automate Your Workflow. Get a real-time feed of all bioXXmed AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for bioXXmed AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Neon Equity AG Logo
An impact investor enabling growth and IPOs for European ESG companies in future-focused sectors.
Germany D77
Newcap Holding Logo
Holding company managing earn-out agreements from divested financial advisory operations.
Denmark NEWCAP
A VCT investing in AIM-quoted and unquoted UK companies to achieve long-term capital growth.
United Kingdom NCA
NEW ENERGY ONE ACQUISITION CORPORATION PLC Logo
A former SPAC that targeted the energy transition sector before ceasing operations.
United Kingdom NEOA
New Tech Capital S.A. Logo
Investment firm managing a diverse portfolio in real estate, stocks, and new technologies.
Poland NTC
New Tech Venture Spolka Akcyjna Logo
A venture capital firm funding high-return ventures in marketing, events, and brand experiences.
Poland NTV
NewTree SA Logo
Impact investor funding Agri-Food tech and food loss prevention for a sustainable food system.
Belgium NEWT
Nexi Logo
European PayTech providing digital payment, card, and banking solutions to merchants and banks.
Italy NEXI
Nordic Financials ASA Logo
Investment firm focused on active ownership and value creation in Nordic industrial markets.
Norway AEGA
PACIFIC GLOBAL HOLDINGS PLC Logo
An investment company building a portfolio of high-growth businesses for capital appreciation.
United Kingdom PCH

Talk to a Data Expert

Have a question? We'll get back to you promptly.